Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bifidobacteria Species Shown to Break Down Gluten Proteins - Nutraceuticals World

What are you searching for?

Sign in
Market Updates, Research

Bifidobacteria Species Shown to Break Down Gluten Proteins

Researchers analyzed the cytotoxic and inflammatory responses to various peptides in an artificial intestinal environment.

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Celiac disease is a chronic autoimmune disorder with no cure aside from a lifelong avoidance of gluten, a cluster of proteins found in wheat and many other grains. That can be challenging though given the state of today’s food system.
 
Researchers have been exploring how gut bacteria, especially Bifidobacteria, could be used as a treatment. Now, scientists publishing the results of laboratory experiments in ACS’ Journal of Agricultural and Food Chemistry reported how specific types of Bifidobacteria work.
 
Humans have many types of bacteria living in their digestive systems, but those with celiac disease have altered levels of “beneficial” and “harmful” gut bacteria. And even if they stick to a strict gluten-free diet, celiac disease patients typically cannot reestablish an ideal gut microbiome on their own.
 
In particular, the levels of bacteria in the Bifidobacteria family are lower in those with the condition than in healthy individuals. These bacteria can chop up gluten proteins into smaller fragments that are not as triggering or damaging in patients, which has led researchers to try using the microbes as a probiotic to treat gastrointestinal diseases. Edson Rodrigues-Filho, Natália E. C. de Almeida and colleagues set out to see exactly how various Bifidobacteria strains break down gluten peptides and what effect these smaller gluten-derived peptides would have on the immune response.
 
The researchers extracted gluten proteins from wheat flour and cultivated four strains of the Bifidobacteria family, both separately and in one large group. In an artificial intestinal environment, B. longum chopped up gluten proteins into the most fragments, compared to the other strains and the mixture of all four strains.
 
From there, the team analyzed the cytotoxic and inflammatory responses to the various peptides, and found that those from the B. longum strain caused the least harm to intestinal cells in petri dishes. These results mark the first identification of specific gluten-derived peptides generated directly from intact gluten proteins by Bifidobacteria activity and the immunological responses to them by human cells, paving the way for further research and perhaps treatments and better patient outcomes, the researchers said.
 
The authors acknowledged funding from the São Paulo Research Foundation and the Brazilian National Council for Scientific and Technological Development. 

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics